Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 12 tags : Fda save search
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Published: 2022-12-12 (Crawled : 00:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.16%
H: 1.41%
C: 0.19%
krasg12 treatment fda lung approval therapeutics cancer
IDEAYA Biosciences Announces Submission of IND Application to the U.S. FDA for PARG Development Candidate IDE161
Published: 2022-12-12 (Crawled : 20:00) - biospace.com/
IDYA | $40.19 -2.38% -2.44% 500K
|
Health Technology
|
| O: 0.18%
H: 3.14%
C: 0.95%
ide161 fda candidate application submission
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
Published: 2022-12-12 (Crawled : 15:00) - biospace.com/
BTCY | $1.25 4.17% 4.0% 87K
|
Manufacturing
|
| O: -0.68%
H: 18.04%
C: 5.54%
fda device cardiac growth
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
Published: 2022-12-12 (Crawled : 14:20) - globenewswire.com
RCEL | $9.405 -3.04% -3.14% 230K
|
Health Technology
|
| O: 1.59%
H: 4.37%
C: 3.18%
fda medical soft tissue
Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA
Published: 2022-12-12 (Crawled : 14:00) - biospace.com/
VRTX | $393.1 -0.27% -0.27% 880K
|
Health Technology
|
| O: 0.96%
H: 0.06%
C: -0.33%
vx-522 fda cleared drug application mrna therapy cystic fibrosis
PolyPid Announces Scheduling of Type D Meeting with U.S. FDA to Discuss SHIELD I Phase 3 Results and Regulatory Pathway for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
Published: 2022-12-12 (Crawled : 13:00) - biospace.com/
PYPD | $4.45 3.29% 1.1K
|
Health Technology
|
| O: -0.14%
H: 9.52%
C: -1.37%
fda meeting infections
FDA Action Alert: Mirati, Coherus/Shanghai Junshi, Gilead and More
Published: 2022-12-12 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
fda
Medivir has completed a successful pre-IND meeting with the FDA
Published: 2022-12-12 (Crawled : 09:00) - prnewswire.com
IGMS | News | $8.1 -11.96% -13.58% 250K
|
Health Technology
|
| O: -0.9%
H: 3.0%
C: 2.36%
fda meeting
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.